#keytruda

Related Stories (2)

Exclusive: Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say - Reuters

Exclusive: Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say Reuters

April 22, 2026

Merck to create separate cancer division as Keytruda patent loss looms - Reuters

Merck to create separate cancer division as Keytruda patent loss looms Reuters

February 23, 2026

Related Pages (1)

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•February 24, 2026